X-group (possible homology)

205 4Fe-4S ferredoxin

Ligands and drugs

4,957
Member domains
1,993
with ligand contacts (≤ 4 Å)
40.2% of members
1,290
with DrugDomain annotations
26.0% of members
354
with a DrugBank compound
7.1% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

75
Proteins with classified ligands
11
Superclasses bound (of 23)
7.8
Superclasses per 20 proteins
broader than 53% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Lipids and lipid-like molecules338.24.01×q < 0.0001
Benzenoids45.40.74×q = 0.73
Homogeneous non-metal compounds1015.90.63×q = 0.17
Organoheterocyclic compounds711.40.61×q = 0.26
Homogeneous metal compounds2036.30.55×q = 5.2e-4
Nucleosides, nucleotides, and analogues1120.40.54×q = 0.02
Organic acids and derivatives311.40.26×q = 7.3e-3
Organic oxygen compounds214.70.14×q < 0.0001
Organohalogen compounds20.29.49×not tested
Mixed metal/non-metal compounds21.61.29×not tested
Organic nitrogen compounds12.40.42×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03429CDLTetrastearoyl cardiolipin79
DB03426DGDDigalactosyl Diacyl Glycerol (Dgdg)61
DB02832SRMSiroheme48
DB04327PEEPhosphatidylethanolamine43
DB03147FADFlavin adenine dinucleotide22
DB18267HEMFerroheme11
DB07349AGA(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE8
DB00172PROProline7
DB02078PG5Triglyme7
DB03350NCOCobalt hexammine ion6
DB13075MQ7Menaquinone 76
DB00160ALAAlanine4
DB02777PLCDiundecyl Phosphatidyl Choline4
DB03247FMNFlavin mononucleotide4
DB16833ADPAdenosine disphosphate4
DB00149LEULeucine3
DB02043LHG1,2-Dipalmitoyl-Phosphatidyl-Glycerole3
DB00151CYSCysteine2
DB00157—NADH2
DB019573CH3-Chlorophenol2

Most frequently bound compounds

PDB ligandNameDomains in contact
SF4IRON/SULFUR CLUSTER1,970
KmetalPOTASSIUM ION125
F3SFE3-S4 CLUSTER124
PC11,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE106
3PE1,2-Distearoyl-sn-glycerophosphoethanolamine102
MGmetalMAGNESIUM ION76
DGDDIGALACTOSYL DIACYL GLYCEROL (DGDG)60
PEE1,2-dioleoyl-sn-glycero-3-phosphoethanolamine56
CAmetalCALCIUM ION52
SRMSIROHEME41
CLCHLORIDE ION40
BVQNORPSEUDO-B1238
CDLCARDIOLIPIN38
HEMPROTOPORPHYRIN IX CONTAINING FE31
B12COBALAMIN25
NAmetalSODIUM ION23
ZNmetalZINC ION15
FADFLAVIN-ADENINE DINUCLEOTIDE13
PLX(9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL11
LMG1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE9